The National Institutes of Health announced plans to test at least four different treatments for long COVID, including Pfizer’s Paxlovid, as potential therapies for the lasting condition, according to a July 31 news release.
Biogen has agreed to pay $7.3 billion to acquire Reata Pharmaceuticals — the maker of a new treatment for a rare genetic disorder. The deal is expected to close by the end of the year.
Of the 13 Pfizer essential drugs the United States Pharmacopeia named as the most likely to go into new or worsened shortages, all of them are already in short supply.
More than two dozen physicians, public health researchers and health policy experts are urging the federal government to publicly share registry data on the safety and efficacy of the Alzheimer's drug Leqembi.
Indiana University Health, based in Indianapolis, recently unveiled its $40 million, 70,000-square-foot shared services pharmacy facility, according to a news release shared with Becker's.
